Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

July 2022; Volume 42,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Acs, MIKLOS

    1. You have access
      Rare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
      ALAEDIN RAJHA, POMPILIU PISO, LASZLO HALMY, IVAN PANCZEL, DAN-SEBASTIAN NEDELCUT, ZOLTAN HEROLD, ATTILA MARCELL SZASZ and MIKLOS ACS
      Anticancer Research July 2022, 42 (7) 3681-3692; DOI: https://doi.org/10.21873/anticanres.15857
  2. Aderhold, CHRISTOPH

    1. You have access
      Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression
      LENA HUBER, RICHARD BIRK, MANUEL KNUETTEL, NICOLE ROTTER, CHRISTOPH ADERHOLD, CLAUDIA SCHERL, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER
      Anticancer Research July 2022, 42 (7) 3403-3411; DOI: https://doi.org/10.21873/anticanres.15827
  3. Ahmadi, NIMA

    1. You have access
      Impact of Macroscopic Tumour Consistency and EPIC in Low-grade Appendiceal Neoplasms With Pseudomyxoma Peritonei
      ERNEST CHENG, RAPHAEL SHAMAVONIAN, JASMINE MUI, JOSH KARPES, KERRY CHEN, NIMA AHMADI and DAVID L. MORRIS
      Anticancer Research July 2022, 42 (7) 3665-3673; DOI: https://doi.org/10.21873/anticanres.15855
  4. Akimoto, KAZUNORI

    1. Open Access
      High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer
      AYAKA OZAKI, HITOMI MOTOMURA, SHOMA TAMORI, CHOTARO ONAGA, YUKA NAGASHIMA, MAHO KOTORI, CHIKA MATSUDA, AKARI MATSUDA, NANAKO MOCHIZUKI, TSUGUMICHI SATO, YASUSHI HARA, KEIKO SATO, YOHEI MIYAGI, YOJI NAGASHIMA, TAKEHISA HANAWA, YOHSUKE HARADA, YUYUN XIONG, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO
      Anticancer Research July 2022, 42 (7) 3299-3312; DOI: https://doi.org/10.21873/anticanres.15818
  5. Akino, YUICHI

    1. Open Access
      Long-term Outcomes of Radiation Therapy for Prostate Cancer in Elderly Patients Aged ≥75 Years
      ERINA NAKANISHI, TAKERO HIRATA, KEISUKE TAMARI, FUMIAKI ISOHASHI, OSAMU SUZUKI, KAZUHIKO HAYASHI, YUJI SEO, YUICHI AKINO, YASUTOSHI FUMIMOTO, KOJI HATANO, ATSUNARI KAWASHIMA, MOTOHIDE UEMURA, SHINICHI SHIMIZU, NORIO NONOMURA and KAZUHIKO OGAWA
      Anticancer Research July 2022, 42 (7) 3529-3536; DOI: https://doi.org/10.21873/anticanres.15839
  6. Akiyama, YASUTO

    1. Open Access
      Characterization of the Immunological Status of Hypermutated Solid Tumors in the Cancer Genome Analysis Project HOPE
      YASUTO AKIYAMA, RYOTA KONDOU, AKIRA IIZUKA, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KENICHI URAKAMI, YUJI SHIMODA, KEIICHI OHSHIMA, AKIO SHIOMI, YASUHISA OHDE, MASANORI TERASHIMA, KATSUHIKO UESAKA, YASUYUKI HIRASHIMA, YOSHIO KIYOHARA, HIROHISA KATAGIRI, TAKASHI SUGINO, AKIFUMI NOTSU, KEITA MORI, MITSURU TAKAHASHI, HIROTSUGU KENMOTSU and KEN YAMAGUCHI
      Anticancer Research July 2022, 42 (7) 3537-3549; DOI: https://doi.org/10.21873/anticanres.15840
  7. Aldarazi, GHASSAN

    1. You have access
      Nestin as a Prognostic Biomarker in High-grade Epithelial Ovarian Cancer Treated by Neoadjuvant Chemotherapy
      HUGO VEYSSIÈRE, GHASSAN ALDARAZI, IOANA MOLNAR, XAVIER DURANDO and NINA RADOSEVIC-ROBIN
      Anticancer Research July 2022, 42 (7) 3583-3594; DOI: https://doi.org/10.21873/anticanres.15845
  8. Ando, KEN

    1. Open Access
      Comparative Analysis of the Antitumor Immune Profiles of Paired Radiotherapy-naive and Radiotherapy-treated Cervical Cancer Tissues
      AYAKA IMAMURA, TAKAHIRO OIKE, HIRO SATO, YUYA YOSHIMOTO, KEN ANDO and TATSUYA OHNO
      Anticancer Research July 2022, 42 (7) 3341-3348; DOI: https://doi.org/10.21873/anticanres.15821
  9. Aoun, SALAH G.

    1. Open Access
      Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review
      PAOLO PALMISCIANO, ANDREW L. CHEN, MAYUR SHARMA, OTHMAN BIN-ALAMER, GIANLUCA FERINI, GIUSEPPE E. UMANA, SALAH G. AOUN and ALI S. HAIDER
      Anticancer Research July 2022, 42 (7) 3251-3259; DOI: https://doi.org/10.21873/anticanres.15814
  10. Arigami, TAKAAKI

    1. You have access
      Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis
      CHIERI NAKAYAMA, KIYONORI TANOUE, TETSUYA IDICHI, HIROKI SHIMOMURA, YOSHIAKI KITA, YUTO HOZAKA, YOSHIAKI SHINDEN, DAISUKE MATSUSHITA, AKIHIRO NAKAJO, TAKAAKI ARIGAMI, YUKO MATAKI, HIROSHI KURAHARA and TAKAO OHTSUKA
      Anticancer Research July 2022, 42 (7) 3373-3380; DOI: https://doi.org/10.21873/anticanres.15824
« Previous (Pages : 1 2 3 4 5 6 ... 52) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (7)
Anticancer Research
Vol. 42, Issue 7
July 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
  • High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer
  • Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer
  • Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review
  • Immunotherapy for Non-small Cell Lung Cancer: Current Agents and Potential Molecular Targets
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire